SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
LEXG-Lexicon Genetics
An SI Board Since August 2000
Posts SubjectMarks Bans Symbol
254 32 0 LXRX
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
229$165 stock offering at $1.15. biz.yahoo.com Know they have a lot in developmenD.Lu-3/16/2010
228I've been out for a while. Might be time to kick the tires again. No rush, nigel bates-3/8/2010
227I spoke direct with the IR head(Dr. Walke) this afternoon. Had a nice conversatArthur Radley-3/8/2010
226THE WOODLANDS, Texas, March 8 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals,nigel bates-3/8/2010
225News today from CEO that they have been contacted by big pharma for their RA druArthur Radley-2/19/2010
224THE WOODLANDS, Texas, Jan. 20 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals,nigel bates-1/20/2010
223LX1031 data announcement... One year to the date from the last LXRX post by Nigepgo-neil-11/13/2009
222Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Successfully Completenigel bates-11/13/2008
221Lexicon gets panned in local newspaper... Accused of taking Texas employment mopgo-neil-7/6/2008
220Lexicon reduces staff by about 20% in effort to bring 10 new INDs to trial by 20pgo-neil-5/28/2008
219Lexicon Files Investigational New Drug Application for LX1032 as a Potential Trenigel bates-12/21/2007
218Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational Nenigel bates-10/16/2007
217Lexicon Drug Candidate for Cognitive Disorders Successfully Completes Phase 1 Clnigel bates-7/31/2007
216Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potentianigel bates-7/3/2007
215Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Develnigel bates-6/18/2007
214Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune Deficiency Fridnigel bates-6/8/2007
213Lexicon Advances LX1031 for Irritable Bowel Syndrome Into Phase 1b Clinical Trianigel bates-4/24/2007
212Lexicon Reports on Anti-Angiogenesis Target Discoveries Tuesday April 17, 5:00 pnigel bates-4/23/2007
211Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets Wednesday Anigel bates-4/23/2007
210Lexicon Advances LX6171 for Cognitive Disorders into Phase 1b Clinical Trial Tuenigel bates-1/30/2007
209I'm still nursing a small holding, FWIW (not much).nigel bates-1/29/2007
208They'll be needing a financing soon and I don't think they should wait tkeokalani'nui-1/29/2007
207Lexicon Genetics Changing Name, Refocusing Business to Achieve Goal of Advancingnigel bates-1/29/2007
206Lexicon Genetics Files Investigational New Drug Application for LX1031 in Irritanigel bates-12/5/2006
205Lexicon Genetics Reports 2006 Third Quarter Financial Results Tuesday October 31nigel bates-10/31/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News